BONE-MARROW AUGMENTATION OF DONOR-CELL CHIMERISM IN KIDNEY, LIVER, HEART, AND PANCREAS ISLET TRANSPLANTATION

Citation
P. Fontes et al., BONE-MARROW AUGMENTATION OF DONOR-CELL CHIMERISM IN KIDNEY, LIVER, HEART, AND PANCREAS ISLET TRANSPLANTATION, Lancet, 344(8916), 1994, pp. 151-155
Citations number
19
Categorie Soggetti
Medicine, General & Internal
Journal title
LancetACNP
ISSN journal
01406736
Volume
344
Issue
8916
Year of publication
1994
Pages
151 - 155
Database
ISI
SICI code
0140-6736(1994)344:8916<151:BAODCI>2.0.ZU;2-9
Abstract
We have previously postulated that donor cell chimerism in organ trans plantation is needed to attain a tolerant state. Here we show that don or cell chimerism can be augmented in organ recipients if they are inf used perioperatively with 3 x 10(8) per kg of unmodified donor bone ma rrow cells and are kept on a conventional immunosuppressive regimen of tacrolimus (FK506) and prednisolone. 36 patients took part, of whom t he first 18 patients have good transplanted kidney (n=10), liver (n=7) , and heart (n=7) function when followed up between 4 and 16 months. A ll patients are well. We found persistent multilineage leucocyte chime rism in blood of 17 recipients by flow cytometry and PCR techniques to detect donor alleles or Y chromosomes in female recipients of male or gans. The use of the 5-antigen HLA matched same sex donor precluded de tection of chimerism in one patient.